Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-13-005297
Filing Date
2013-11-12
Accepted
2013-11-12 17:08:07
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q biei_10q.htm 10-Q 926169
2 FIRST AMENDMENT TO CONVERTIBLE PROMISSORY NOTE biei_ex104.htm EX-10.4 14907
3 CERTIFICATION biei_ex311.htm EX-31.1 15134
4 CERTIFICATION biei_ex312.htm EX-31.2 16013
5 CERTIFICATION biei_ex321.htm EX-32.1 6662
6 CERTIFICATION biei_ex322.htm EX-32.2 6533
  Complete submission text file 0001477932-13-005297.txt   4913525

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT biei-20130930.xml EX-101.INS 710658
8 XBRL TAXONOMY EXTENSION SCHEMA biei-20130930.xsd EX-101.SCH 57670
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE biei-20130930_cal.xml EX-101.CAL 39427
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE biei-20130930_def.xml EX-101.DEF 88448
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE biei-20130930_lab.xml EX-101.LAB 285588
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biei-20130930_pre.xml EX-101.PRE 188433
Mailing Address P.O. BOX 31374 EL PASO TX 79930
Business Address P.O. BOX 31374 EL PASO TX 79930 814 786 8849
PREMIER BIOMEDICAL INC (Filer) CIK: 0001515740 (see all company filings)

EIN.: 272635666 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54563 | Film No.: 131211260
SIC: 2836 Biological Products, (No Diagnostic Substances)